Fierce Pharma Asia—Merck KGaA and Hengrui's PARP deal; Novartis and Takeda's employee dispute; toripalimab's FDA nod

3rd November 2023 Uncategorised 0

Fierce Pharma Asia—Merck KGaA and Hengrui’s PARP deal; Novartis and Takeda’s employee dispute; toripalimab’s FDA nod
aliu
Thu, 11/02/2023 – 23:13

More: Fierce Pharma Asia—Merck KGaA and Hengrui's PARP deal; Novartis and Takeda's employee dispute; toripalimab's FDA nod
Source: fierce